Nouscom's Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to 'Intercept' Cancer in Subjects with Lynch Syndrome

Lynch Syndrome is a common hereditary condition associated with a genetic predisposition to and high-risk of developing colorectal and other cance...

Related Keywords

Texas ,United States ,Switzerland ,San Diego ,California ,Rick Davis ,Sylvie Berrebi ,Elisa Scarselli ,Anna Morena Dalise ,Richard Davis ,Eduardo Vilar Sanchez ,National Cancer Institute ,Cancer Prevention Clinical Trials Network ,Linkedin ,Bristol Myers Squibb ,Janssen Research Development ,University Of Texas Md Anderson Cancer Center ,Society For Immunotherapy Of Cancer ,Merck Co Inc ,Lynch Syndrome ,National Cancer ,Late Breaking Oral Abstract Presentation ,Annual Meeting ,Late Breaking Abstract ,Microsatellite Instable ,Cancer Center ,Clinical Cancer Prevention ,Principal Investigator ,Chief Scientific Officer ,Chief Operating Officer ,Abstract Presentation Details ,Anna Morenad Alise ,Myeloproliferative Neoplasms ,Janssen Research ,Bristol Myers ,Mark Swallow ,